[HTML][HTML] DLBCL arising from indolent lymphomas: how are they different?

EM Parry, S Roulland, J Okosun - Seminars in Hematology, 2023 - Elsevier
Transformation to diffuse large B-cell lymphoma (DLBCL) is a recognized, but unpredictable,
clinical inflection point in the natural history of indolent lymphomas. Large retrospective …

The many faces of nodal and splenic marginal zone lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop

A Zamò, M Van Den Brand, F Climent, L De Leval… - Virchows Archiv, 2023 - Springer
Session 3 of the lymphoma workshop of the XXI joint meeting of the European Association
for Haematopathology and the Society for Hematopathology took place in Florence, Italy, on …

Marginal zone lymphoma: 2023 update on diagnosis and management

CY Cheah, JF Seymour - American Journal of Hematology, 2023 - Wiley Online Library
Disease overview Marginal zone lymphomas (MZL) are collectively the second most
common type of indolent lymphoma. Diagnosis Three subtypes of MZL are recognized …

[HTML][HTML] BCL3 rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases

A Carbo-Meix, F Guijarro, L Wang, M Grau… - …, 2024 - ncbi.nlm.nih.gov
Abstract The t (14; 19)(q32; q13) often juxtaposes BCL3 with immunoglobulin heavy chain
(IGH) resulting in overexpression of the gene. In contrast to other oncogenic translocations …

Transformation in Marginal Zone Lymphoma: Results from a Prospective Cohort and a Meta-Analysis of the Literature

C Bommier, BL Link, BJ Gysbers, MJ Maurer… - Blood …, 2024 - ashpublications.org
Marginal zone lymphoma (MZL) includes extranodal (EMZL), splenic (SMZL), and nodal
(NMZL) subtypes. Histological transformation (HT) to large B-cell lymphomas is well …

Advances in the treatment of relapsed/refractory marginal zone lymphoma

H Wang, X Wan, Y Zhang, J Guo, O Bai - Frontiers in Oncology, 2024 - frontiersin.org
Marginal zone lymphoma (MZL) is the second most common subtype of inert B-cell non-
Hodgkin's lymphoma, accounting for 5–15% of non-Hodgkin's lymphoma cases. Patients …

Understanding splenic B‐cell lymphoma/leukaemia with prominent nucleoli: Diagnosis, underpinnings for disease classification and future directions

KN Naresh - British Journal of Haematology, 2024 - Wiley Online Library
The 5th edition of the WHO classification of haematolymphoid tumours (WHO‐HAEM5)
introduced a new category, splenic B‐cell lymphoma/leukaemia with prominent nucleoli …

Intraparenchymal low-grade B-cell lymphomas of the central nervous system: Clinicopathologic and molecular analysis of three cases and a review of the literature

MTD de Vera, FJD Crespo, R Manso, AP Coello… - Annals of Diagnostic …, 2024 - Elsevier
Primary central nervous system (CNS) lymphomas represent 1% of all non-Hodgkin
lymphomas, with diffuse large B-cell lymphomas as the prevailing subtype. Low-grade B-cell …

[HTML][HTML] The genomic and molecular landscape of splenic marginal zone lymphoma, biological and clinical implications

A Mirandari, H Parker, M Ashton-Key… - … of Targeted Anti …, 2024 - ncbi.nlm.nih.gov
Splenic marginal zone lymphoma (SMZL) is a rare, predominantly indolent B-cell lymphoma
constituting fewer than 2% of lymphoid neoplasms. However, around 30% of patients have a …

Progressive TP53 inactivation in an aggressive splenic diffuse red pulp small B-cell lymphoma

MM Tzioni, A Clipson, Z Chen, F Cucco… - Leukemia & …, 2024 - Taylor & Francis
Splenic diffuse red pulp small B-cell lymphoma (SdrPL) is a rare small B-cell lymphoma
involving the spleen, bone marrow and peripheral blood, initially thought to be a variant of …